New data on limno-terrestrial rotifers of the world. [PDF]
Lukashanets D +15 more
europepmc +1 more source
Inflammatory niches as spatial drivers of disease mechanisms and targets for personalized treatment
This study provides a comprehensive review of how spatial transcriptomics reveals disease‐specific inflammatory niches across multiple skin disorders, highlighting key immune–stromal, neuro–immune and metabolic interactions that were previously unappreciated in non‐spatial analyses. Abstract Disease states are increasingly recognized as being shaped by
Rundong Jiang +3 more
wiley +1 more source
Succession of Lichens in Front of Retreating Glaciers in Sweden and Norway. [PDF]
Halda JP, Košnar J, Lukešová A.
europepmc +1 more source
Global consensus on the management of melanin hyperpigmentation disorders
A global Delphi consensus of 10 dermatology experts established evidence‐based recommendations for melanin hyperpigmentation disorders, providing unified classification, photoprotection guidance and treatment algorithms. This framework harmonizes terminology and supports individualized management across diverse skin types and health systems.
Thierry Passeron +9 more
wiley +1 more source
Is the Reindeer Lichen <i>Cladonia arbuscula</i> Really Producing Isousnic Acid? A Chemotaxonomy Query. [PDF]
Ísleifsdóttir D +8 more
europepmc +1 more source
Basal cell carcinoma occurring in a lesion of lichen planus: Coincidence or causation?
Saumya Panda, Debabrata Bandyopadhyay
openalex +1 more source
Dermatology 2.0: Precision medicine for inflammatory skin diseases
Digital immune mapping of transcriptomics profiles from inflammatory skin disease biopsies enables precise molecular diagnosis, quantification of immune modules and personalized therapy selection by matching dominant immune signatures to targeted treatments.
Jeremy Di Domizio +4 more
wiley +1 more source
Paired-omics-based exploration and characterization of biosynthetic diversity in lichenized fungi. [PDF]
Singh G +14 more
europepmc +1 more source
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat +22 more
wiley +1 more source

